Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Amgen and Kite in $1bn cancer immunotherapy tie up

Latest major research deal in growing area of oncology

Novartis day

FDA close to first biosimilar approval

US regulator’s advisory board recommends Novartis’ version of Amgen’s Neupogen

- PMLiVE

Blue Latitude boosts its team

Blue Latitude has appointed Ben Routley, Natalie Seebeck and Kasia Zygadlewicz to its team, following a series of new business wins and increased work from existing clients.

Blue Latitude Health

- PMLiVE

Janssen partners with Isis on stomach conditions

Will develop treatments that target RNA in people with autoimmune disorders

- PMLiVE

Huntsworth names Paul Taaffe as CEO

Former head of comms at Groupon will replace Lord Chadlington in April

- PMLiVE

Lilly names head of corporate business development

Promotion for Darren Carroll

- PMLiVE

Janssen and Gilead extend HIV collaboration

Will develop single tablet regimen that combines Prezista, Tybost, emtricitabine and tenofovir alafenamide

- PMLiVE

Organs-in-a-dish aid drug discovery

Using stem cells to generate complex tissues and organs in the lab is promising to tackle a key bottleneck in drug discovery

- PMLiVE

FDA approved 44 new drugs in 2014

AstraZeneca leads pharma success with four approvals, but Bayer had a year to forget  

- PMLiVE

NICE rejects pancreatic cancer regimen over cost concerns

Charity says draft decision to deny Abraxane/Gemzar combo is a ‘backwards step’ for the NHS pricing body

- PMLiVE

Angelini to market Ariad’s Iclusig in Eastern Europe

Comes after leukaemia drug passes EMA safety review

- PMLiVE

Dendreon to go to auction without initial bidder

A selection for a bidder wanting to pay the minimum price has not been made

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links